Insmed Inc (INSM)vsWhitehawk Therapeutics, Inc. (WHWK)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
WHWK
Whitehawk Therapeutics, Inc.
$3.59
-1.64%
HEALTHCARE · Cap: $169.44M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 8387% more annual revenue ($606.42M vs $7.14M). INSM leads profitability with a -2.1% profit margin vs -2.9%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
WHWK
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -21.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : WHWK
The strongest argument for WHWK centers on Price/Book.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : WHWK
The primary concerns for WHWK are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
WHWK generates stronger free cash flow (-17M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
INSM scores higher overall (39/100 vs 24/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Whitehawk Therapeutics, Inc.
HEALTHCARE · BIOTECHNOLOGY · USA
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. The company is headquartered in Morristown, New Jersey.
Visit Website →Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?